Science Explorer Back to mapMap
Discussion
Researcher · Brown Foundation · United States

Ningyan Zhang

Ningyan Zhang publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Immune Cell Function and Interaction.

ORCID 0000-0002-4348-2180 OpenAlex
World rank
#81,471
of 7,710,434 ranked researchers
Rank in United States
#31,440
of 1,627,098
Works
295
Citations
9.2k
Citations per work
31.2
h-index
52
i10-index 112Top 3.3% in Molecular Biology
Ningyan Zhang

What does Ningyan Zhang research?

Ningyan Zhang's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (12%).

Everything else: 114 works · 38.7% of their workLife Sciences: 94 works · 31.8% of their workBiochemistry, Genetics and Molecular Biology: 57 works · 19.4% of their workMolecular Biology: 45 works · 15.4% of their workCancer Research: 12 works · 4.0% of their workImmunology and Microbiology: 37 works · 12.4% of their workImmunology: 37 works · 12.4% of their workHealth Sciences: 87 works · 29.5% of their workMedicine: 87 works · 29.5% of their workOncology: 39 works · 13.2% of their workEpidemiology: 26 works · 8.9% of their workRadiology, Nuclear Medicine and Imaging: 22 works · 7.4% of their workTHEIR WORKNingyan Zhang295works
Life Sciences32%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else11438.7%
    1. Biochemistry, Genetics and Molecular Biology5719.4%
    2. Immunology and Microbiology3712.4%
    1. Medicine8729.5%
  1. 1Molecular Biology15% of their works
  2. 2Oncology13% of their works
  3. 3Immunology12% of their works
  4. 4Epidemiology9% of their works
  5. 5Radiology, Nuclear Medicine and Imaging7% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Ningyan Zhang's research?

The keywords of their largest research topics: Fc Receptors, Therapeutic Antibodies, Cancer Immunotherapy, Breast Cancer, HER2, Immunity, Cytomegalovirus and Infection.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Fc Receptors411 topic
  2. Therapeutic Antibodies411 topic
  3. Cancer Immunotherapy282 topics
  4. Breast Cancer271 topic
  5. HER2271 topic
  6. Immunity242 topics
  7. Cytomegalovirus211 topic
  8. Infection211 topic
  9. NK Cell Recognition211 topic
  10. Natural Killer Cells211 topic
  11. CAR T Cells171 topic
  12. Chimeric Antigen Receptor171 topic
  13. Herpes Zoster161 topic
  14. Herpesviruses161 topic
  15. Activation131 topic
  16. Macrophage131 topic
  17. Antigen Presentation111 topic
  18. Dendritic Cells111 topic

Where does Ningyan Zhang work?

Ningyan Zhang's main affiliation in the publication record is Brown Foundation, United States.

How many publications and citations does Ningyan Zhang have?

OpenAlex counts 295 works and 9,208 citations for Ningyan Zhang, an h-index of 52, ranking #81,471 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ningyan Zhang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.